Qualitative differences in the discriminative stimulus effects of low and high doses of caffeine in the rat
- PMID: 1890622
Qualitative differences in the discriminative stimulus effects of low and high doses of caffeine in the rat
Abstract
Caffeine engenders qualitatively different subjective effects in humans at low and high doses. Low doses of caffeine are mildly reinforcing and produce psychomotor stimulation. High doses of caffeine can produce subjective feelings of anxiety, dysphoria and depression. The present study was designed to model these different subjective states in rats using a discrete trial shock avoidance/escape drug discrimination paradigm. Rats were trained to discriminate between i.p. injections of saline and either 10 or 56 mg/kg of caffeine. Rats trained at 10 mg/kg of caffeine acquired the discrimination in an average of 93 sessions and generalized completely to a variety of xanthine and nonxanthine behavioral stimulants including: d-amphetamine, apomorphine, 7-(beta-chloroethyl)theophylline, 9-chloro-2-(2-furanyl)-5,6-dihydro-1, 2,4-triazolo[1,5-c]quinazolin-5-imine (CGS 15943), cocaine, 1,7-dimethylxanthine, diethylpropion, beta-hydroxyethyltheophylline, methylphenidate, phenidimetrazine and theophylline. Rats trained at 56 mg/kg of caffeine acquired the discrimination in an average of 43 sessions and generalized completely only to theophylline. A variety of drugs representing diverse pharmacologic classifications including: benzodiazepine inverse agonists, pentylenetetrazol, yohimbine, ethylketocyclazocine and phencyclidine, were not generalized from either training dose, demonstrating the pharmacologic specificity of the discrimination. The discriminative effects of 10 mg/kg of caffeine appear to derive from a state of behavioral arousal, possibly mediated by catecholamines, and parallel the subjective effects produced by low doses of caffeine in humans. The discriminative effects of 56 mg/kg of caffeine are qualitatively different from those of 10 mg/kg but cannot be defined further at this time.
Similar articles
-
Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine.J Pharmacol Exp Ther. 1999 Mar;288(3):1053-73. J Pharmacol Exp Ther. 1999. PMID: 10027843
-
Discriminative stimulus properties of caffeine in the rat: noradrenergic mediation.J Pharmacol Exp Ther. 1986 Dec;239(3):706-14. J Pharmacol Exp Ther. 1986. PMID: 2432216
-
Changes in the ambulatory activity and discriminative stimulus effects of psychostimulant drugs in rats chronically exposed to caffeine: effect of caffeine dose.J Pharmacol Exp Ther. 2000 Dec;295(3):1101-11. J Pharmacol Exp Ther. 2000. PMID: 11082446
-
The role of dopamine in the behavioral effects of caffeine in animals and humans.Pharmacol Biochem Behav. 1997 Jul;57(3):533-41. doi: 10.1016/s0091-3057(96)00435-2. Pharmacol Biochem Behav. 1997. PMID: 9218278 Review.
-
Low, but not high, dose caffeine is a readily available probe for adenosine actions.Mol Aspects Med. 2017 Jun;55:20-25. doi: 10.1016/j.mam.2016.11.011. Epub 2016 Nov 30. Mol Aspects Med. 2017. PMID: 27915051 Review.
Cited by
-
The scientific case that nicotine is addictive.Psychopharmacology (Berl). 1995 Jan;117(1):2-10; discussion 14-20. doi: 10.1007/BF02245088. Psychopharmacology (Berl). 1995. PMID: 7724697 Review.
-
Caffeine provokes adverse interactions with 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and related psychostimulants: mechanisms and mediators.Br J Pharmacol. 2012 Nov;167(5):946-59. doi: 10.1111/j.1476-5381.2012.02065.x. Br J Pharmacol. 2012. PMID: 22671762 Free PMC article. Review.
-
Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens.J Neurosci. 2002 Aug 1;22(15):6321-4. doi: 10.1523/JNEUROSCI.22-15-06321.2002. J Neurosci. 2002. PMID: 12151508 Free PMC article.
-
Drug discrimination by humans compared to nonhumans: current status and future directions.Psychopharmacology (Berl). 1993;111(3):259-70. doi: 10.1007/BF02244940. Psychopharmacology (Berl). 1993. PMID: 7870962 Review.
-
Caffeine stimulates locomotor activity in the mammalian spinal cord via adenosine A1 receptor-dopamine D1 receptor interaction and PKA-dependent mechanisms.Neuropharmacology. 2016 Feb;101:490-505. doi: 10.1016/j.neuropharm.2015.10.020. Epub 2015 Oct 19. Neuropharmacology. 2016. PMID: 26493631 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical